Carvacrol Conjugated Zinc Oxide Nanoparticles as Prospective Agents against Clinically Isolated Carbapenem Resistant Acinetobacter Species. Medical Forum Monthly, [S. l.], v. 33, n. 9, 2024. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/1042.. Acesso em: 26 dec. 2025.